COVID-19 patients characteristics
| . | Nonhospitalized . | Hospitalized . | ICU . | Total . |
|---|---|---|---|---|
| Total N | 120 | 241 | 207 | 568 |
| Age, y | ||||
| 50-59 | 6 (5%) | 90 (37%) | 61 (29%) | 157 (28%) |
| 60-69 | 104 (86%) | 50 (21%) | 77 (37%) | 231 (41%) |
| 70-79 | 8 (7%) | 67 (28%) | 53 (26%) | 128 (23%) |
| 80+ | 2 (2%) | 34 (14%) | 16 (8%) | 52 (9%) |
| Sex | ||||
| Female | 71 (59%) | 107 (45%) | 48 (23%) | 226 (40%) |
| Male | 49 (41%) | 134 (55%) | 159 (77%) | 342 (60%) |
| Ethnicity | ||||
| White | 114 (95%) | 196 (81%) | 143 (69%) | 453 (80%) |
| Non-White | 6 (5%) | 27 (11%) | 35 (17%) | 68 (12%) |
| Other | 0 (0%) | 8 (3%) | 21 (10%) | 29 (5%) |
| NA | 0 (0%) | 10 (4%) | 8 (4%) | 18 (3%) |
| Smoking | ||||
| Never | 40 (33%) | 134 (56%) | 107 (52%) | 281 (49%) |
| Former | 26 (22%) | 69 (29%) | 62 (30%) | 157 (28%) |
| Current | 0 (0%) | 8 (3%) | 7 (3%) | 15 (3%) |
| Missing | 54 (45%) | 30 (12%) | 31 (15%) | 115 (20%) |
| Hypertension | ||||
| No | 38 (32%) | 24 (10%) | 21 (10%) | 83 (15%) |
| Yes | 31 (26%) | 24 (10%) | 33 (16%) | 88 (15%) |
| Missing | 51 (41%) | 193 (80%) | 153 (74%) | 397 (70%) |
| CVD | ||||
| No | 61 (51%) | 172 (71%) | 154 (74%) | 387 (68%) |
| Yes | 8 (6%) | 64 (27%) | 47 (23%) | 119 (21%) |
| Missing | 51 (43%) | 5 (2%) | 6 (3%) | 62 (11%) |
| COPD/asthma | ||||
| No | 56 (47%) | 194 (80%) | 174 (84%) | 424 (75%) |
| Yes | 14 (12%) | 41 (17%) | 27 (13%) | 82 (14%) |
| Missing | 50 (42%) | 6 (3%) | 6 (3%) | 62 (11%) |
| Diabetes | ||||
| No | 56 (47%) | 176 (73%) | 138 (67%) | 370 (65%) |
| Yes | 9 (7%) | 59 (24%) | 62 (30%) | 130 (23%) |
| Missing | 55 (46%) | 6 (3%) | 7 (3%) | 68 (12%) |
| Cancer (neoplasm and hematological) | ||||
| No | 66 (55%) | 208 (86%) | 190 (92%) | 464 (82%) |
| Yes | 4 (3%) | 22 (9%) | 11 (6%) | 38 (7%) |
| Missing | 50 (42%) | 11 (5%) | 5 (2%) | 66 (12%) |
| Immunodeficiency | ||||
| No | 71 (59%) | 204 (85%) | 181 (88%) | 456 (80%) |
| Yes | 0 | 30 (12%) | 17 (8%) | 47 (8%) |
| Missing | 49 (41%) | 7 (3%) | 9 (4%) | 65 (11%) |
| . | Nonhospitalized . | Hospitalized . | ICU . | Total . |
|---|---|---|---|---|
| Total N | 120 | 241 | 207 | 568 |
| Age, y | ||||
| 50-59 | 6 (5%) | 90 (37%) | 61 (29%) | 157 (28%) |
| 60-69 | 104 (86%) | 50 (21%) | 77 (37%) | 231 (41%) |
| 70-79 | 8 (7%) | 67 (28%) | 53 (26%) | 128 (23%) |
| 80+ | 2 (2%) | 34 (14%) | 16 (8%) | 52 (9%) |
| Sex | ||||
| Female | 71 (59%) | 107 (45%) | 48 (23%) | 226 (40%) |
| Male | 49 (41%) | 134 (55%) | 159 (77%) | 342 (60%) |
| Ethnicity | ||||
| White | 114 (95%) | 196 (81%) | 143 (69%) | 453 (80%) |
| Non-White | 6 (5%) | 27 (11%) | 35 (17%) | 68 (12%) |
| Other | 0 (0%) | 8 (3%) | 21 (10%) | 29 (5%) |
| NA | 0 (0%) | 10 (4%) | 8 (4%) | 18 (3%) |
| Smoking | ||||
| Never | 40 (33%) | 134 (56%) | 107 (52%) | 281 (49%) |
| Former | 26 (22%) | 69 (29%) | 62 (30%) | 157 (28%) |
| Current | 0 (0%) | 8 (3%) | 7 (3%) | 15 (3%) |
| Missing | 54 (45%) | 30 (12%) | 31 (15%) | 115 (20%) |
| Hypertension | ||||
| No | 38 (32%) | 24 (10%) | 21 (10%) | 83 (15%) |
| Yes | 31 (26%) | 24 (10%) | 33 (16%) | 88 (15%) |
| Missing | 51 (41%) | 193 (80%) | 153 (74%) | 397 (70%) |
| CVD | ||||
| No | 61 (51%) | 172 (71%) | 154 (74%) | 387 (68%) |
| Yes | 8 (6%) | 64 (27%) | 47 (23%) | 119 (21%) |
| Missing | 51 (43%) | 5 (2%) | 6 (3%) | 62 (11%) |
| COPD/asthma | ||||
| No | 56 (47%) | 194 (80%) | 174 (84%) | 424 (75%) |
| Yes | 14 (12%) | 41 (17%) | 27 (13%) | 82 (14%) |
| Missing | 50 (42%) | 6 (3%) | 6 (3%) | 62 (11%) |
| Diabetes | ||||
| No | 56 (47%) | 176 (73%) | 138 (67%) | 370 (65%) |
| Yes | 9 (7%) | 59 (24%) | 62 (30%) | 130 (23%) |
| Missing | 55 (46%) | 6 (3%) | 7 (3%) | 68 (12%) |
| Cancer (neoplasm and hematological) | ||||
| No | 66 (55%) | 208 (86%) | 190 (92%) | 464 (82%) |
| Yes | 4 (3%) | 22 (9%) | 11 (6%) | 38 (7%) |
| Missing | 50 (42%) | 11 (5%) | 5 (2%) | 66 (12%) |
| Immunodeficiency | ||||
| No | 71 (59%) | 204 (85%) | 181 (88%) | 456 (80%) |
| Yes | 0 | 30 (12%) | 17 (8%) | 47 (8%) |
| Missing | 49 (41%) | 7 (3%) | 9 (4%) | 65 (11%) |
COPD, chronic obstructive pulmonary disease; NA, not available.